Skip to main content

Advertisement

Table 1 Patient characteristics

From: Use of a multi-drug regimen gemcitabine, 5-fluorouracil, irinotecan, cisplatin, bevacizumab, docetaxel, and cyclophosphamide (GFIP/BDC) for heavily pretreated relapsed epithelial ovarian, fallopian tube and primary peritoneal cancer

Characteristic No. of Patients Percentage (%)
Primary Site of Malignancy
 Ovary 17 85
 Fallopian Tube 1 5
 Peritoneal 2 10
Histologic Type
 Papillary serous 18 90
 Endometriod 1 5
 Carcinosarcoma 1 5
Histologic Grade
 G2 3 15
 G3 17 85
Stage at Initial Diagnosis
 IA 1 5
 IIIA 1 5
 IIIB 1 5
 IIIC 13 65
 IV 4 20
Primary Cytoreductive Surgery
 No gross residual 4 20
 Optimal 9 45
 Suboptimal 1 5
 Unknown 6 30